6952-63-2

Usage

Uses

Used in Industrial Applications:
(Z)-N-octadecyl-9-octadecenamide is used as a lubricant, release agent, and antifoaming agent for its ability to reduce friction, facilitate the release of materials from surfaces, and control foam formation, respectively. Its performance in these roles is attributed to its long-chain structure and amphiphilic nature.
Used in Cosmetic and Pharmaceutical Products:
In the cosmetic and pharmaceutical industries, (Z)-N-octadecyl-9-octadecenamide is utilized as an emollient and skin-conditioning agent. Its capacity to soften and smooth the skin, as well as to improve skin hydration and texture, makes it a valuable ingredient in skincare formulations.
Used in Agricultural Chemicals:
(Z)-N-octadecyl-9-octadecenamide also finds application in the production of insecticides and herbicides, capitalizing on its pesticidal properties to control pests and weeds in agricultural settings. This use is supported by its effectiveness in managing unwanted organisms while maintaining a low environmental impact.
The chemical is considered to be of low toxicity, and when used as intended, it is not known to pose significant risks to human health or the environment. This safety profile, combined with its diverse utility, underscores the value of (Z)-N-octadecyl-9-octadecenamide in various commercial and industrial applications.

InChI:InChI=1/C36H71NO/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-36(38)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h18,20H,3-17,19,21-35H2,1-2H3,(H,37,38)/b20-18-

Upstream product

• 112-80-1 cis-Octadecenoic acid 
• 124-30-1 1-aminooctadecane 
• 17363-90-5 p-nitrophenyl oleate 
• 112-79-8 Elaidic acid 

Relevant academic research and scientific papers

Utilizing the amidation reaction to address the "cooperative effect" of carboxylic acid/amine on the size, shape, and multicolor output of fluoride upconversion nanoparticles

Here we elucidate the "cooperative effect" of carboxylic acid/amine on the size, shape, and multicolor output of fluoride upconversion nanoparticles (UCNPs) utilizing the amidation reaction. During the synthesis of NaYF4 UCNPs using oleic acid (OA) and octadecylamine (OM) as ligands, the evolution of the reaction solution was monitored by FT-IR and proton nuclear magnetic resonance (1H-NMR) spectroscopy. It is shown that N-octadecyloleamide (OOA) was formed and tightly bonded to the surface of the fluoride UCNPs. FT-IR and 1H-NMR analyses point towards a two-step OOA formation mechanism where OA initially reacted with OM to form an acid-base complex (C17H33CO2- +NH 3C18H37) in reaction mixture, which further transformed into OOA before the nucleation of fluoride UCNPs at elevated temperature. Importantly, we find that the interaction of OOA with the surfaces of the fluoride UCNPs was stronger than that of OM, and that OOA could strongly quench the green-emitting levels of excited Er3+ ions. A series of control experiments and analyses demonstrate that OOA was not only responsible for the control of the size and shape of NaYF4: 20% Yb, 2% Er UCNPs, but also for the multicolor tuning of them. Those observations reveal that the "cooperative effect" between carboxylic acid and amine results from the amidation reaction and its product. This paper provides us with some new deep insights into the "cooperative effect" of carboxylic acid and amine during the synthesis of inorganic nanoparticles under thermolysis. Furthermore, other lanthanide-ion doped fluoride UCNPs with controlled size, shape and multicolor output can also be obtained in the same way.

Stabilization of polynucleotide complexes

Polynucleotide complexes are stabilized by adding a cryoprotectant compound and lyophilizing the resulting formulation. The lyophilized formulations are milled or sieved into a dry powder formulation which may be used to deliver the polynucleotide complex. Delivery of the polynucleotide to a desired cell tissue is accomplished by contacting the tissue with the powder to rehydrate it. In a preferred embodiment, a dry powder formulation is used to induce genetic modification of a patient's lung tissue.